JANE STREET GROUP, LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 253 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,502,113
-11.7%
549,915
+36.7%
0.00%0.0%
Q2 2023$2,832,311
+605.7%
402,317
+512.5%
0.00%
Q1 2023$401,330
-38.4%
65,684
-35.6%
0.00%
Q4 2022$651,262
+11.7%
101,919
+67.6%
0.00%
Q3 2022$583,000
-59.4%
60,818
-53.3%
0.00%
-100.0%
Q2 2022$1,436,000
-85.1%
130,117
-77.5%
0.00%
-66.7%
Q1 2022$9,622,000
+40.2%
577,920
+60.7%
0.00%
+50.0%
Q4 2021$6,865,000
-12.5%
359,617
+13.1%
0.00%
-33.3%
Q3 2021$7,843,000
-46.9%
318,034
-43.9%
0.00%
-50.0%
Q2 2021$14,758,000
+182.8%
567,196
+244.2%
0.01%
+100.0%
Q1 2021$5,218,000
-62.3%
164,787
-44.8%
0.00%
-57.1%
Q4 2020$13,844,000
+42.1%
298,337
+0.8%
0.01%
+40.0%
Q3 2020$9,742,000
-40.6%
295,908
-50.4%
0.01%
-58.3%
Q2 2020$16,390,000
+189.4%
597,098
+215.6%
0.01%
+100.0%
Q1 2020$5,664,000
+599.3%
189,213
+546.8%
0.01%
+500.0%
Q4 2019$810,000
+35.0%
29,255
-11.3%
0.00%0.0%
Q3 2019$600,000
-42.7%
32,982
-22.8%
0.00%
-50.0%
Q2 2019$1,048,000
+539.0%
42,724
+101.5%
0.00%
+100.0%
Q3 2017$164,00021,2040.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
MHR Fund Management 11,997,103$84,459,60511.88%
MPM BioImpact LLC 2,950,118$20,768,8314.18%
Perceptive Advisors 14,036,410$98,816,3262.86%
Velan Capital Investment Management LP 240,000$1,689,6001.57%
Parametrica Management Ltd 96,500$679,3601.31%
Boxer Capital, LLC 3,705,133$26,0841.21%
Soleus Capital Management, L.P. 1,239,777$8,728,0300.97%
Opaleye Management Inc. 421,000$2,963,8400.71%
683 Capital Management, LLC 1,400,000$9,856,0000.71%
RICE HALL JAMES & ASSOCIATES, LLC 1,758,759$12,381,6650.70%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders